Reveal-Dx is a Seattle-based software company whose vision is to dramatically improve lung cancer outcomes. We do this by delivering the most advanced, radiomics and AI enabled, lung cancer decision support software to the mainstream market, driving the optimal clinical pathway for each patient. Reveal-Dx is a young company, started in early 2021, but we jump started the company by purchasing the assets of Mindshare Medical in March. Mindshare had invested millions of dollars and over 5 years of research developing core, patented algorithms that were actively being deployed in the clinic for validation.